Gliapharm SA develops medicines that target glial cells to enhance brain energy metabolism and support neuronal function. The company uses its GliaX™ discovery platform to identify molecular targets and small‑molecule candidates and advances preclinical translational models and biomarkers.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered2
Discovery Platform GliaX™
Proprietary drug discovery platform for identifying and characterizing molecular targets and novel drug candidates acting on glial cell pathways; used internally and with academic and industry partners.
Medicines for neurological disorders
Medicines in development targeting astrocytes and metabolic pathways to improve brain energy, neuroprotection and cognitive functions in multiple neurological diseases.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.